New drug DD-S052P tested in humans for first time
Knowledge-focused
Completed
This early-phase trial tested the safety and tolerability of a new drug called DD-S052P in 64 healthy adults. Participants received either the drug or a placebo as an intravenous infusion, in single or multiple doses. The study monitored side effects, vital signs, and lab results…
Phase: PHASE1 • Sponsor: HLB Science • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC